|
Rational Biotechnology focuses on its competence in multi-focal research
and early stage development; Rational seeks to commercialize research offspring
through its subsidiary or partner. For strategic partnership or licensing
opportunities, please contact Rational's business development team.
Partner and Subsidiary
Rational's current subsidiary and commercialization partner include:
|
 |
Optivia Biotechnology provides the industry's most comprehensive transporter
assay products and services to help pharmaceutical companies utilize the
full potentials of transporter proteins in developing better drugs. Optivia
acquired an exclusive license on Rational's functional transporter assay
platform in 2007.
Visit Optivia at: www.optiviabio.com |
|
|
|
Return
Research Collaboration
Rational invites academic and research organizations to collaborate in the following areas:
- Manage and treat liver diseases using RNAi technology
- Develop and characterize in vitro models for Blood-Brain-Barrier (BBB)
and CNS delivery
- Transcription factor profiling and its applications in pharmacogenomics
and chemicogenomics.
- Functional genomics and target validation using human primary cells and siRNA
- Sonoporation mediated in vivo gene delivery
Return
Licensing
Rational has following patent-pending or proprietary technologies available
for non-exclusive or field-limiting licensing.
- Human primary cell based assay platform
- Functional transcription factor profiling assays
Return
|
